nodes	percent_of_prediction	percent_of_DWPC	metapath
Varenicline—Pain—Sorafenib—liver cancer	0.00233	0.00233	CcSEcCtD
Varenicline—Constipation—Sorafenib—liver cancer	0.00233	0.00233	CcSEcCtD
Varenicline—Hypertonia—Doxorubicin—liver cancer	0.00229	0.00229	CcSEcCtD
Varenicline—Eczema—Epirubicin—liver cancer	0.00228	0.00228	CcSEcCtD
Varenicline—Eye pain—Epirubicin—liver cancer	0.00227	0.00227	CcSEcCtD
Varenicline—Mental disability—Doxorubicin—liver cancer	0.00227	0.00227	CcSEcCtD
Varenicline—Gastrointestinal pain—Sorafenib—liver cancer	0.00223	0.00223	CcSEcCtD
Varenicline—Lymphadenopathy—Doxorubicin—liver cancer	0.00222	0.00222	CcSEcCtD
Varenicline—Renal failure acute—Epirubicin—liver cancer	0.00222	0.00222	CcSEcCtD
Varenicline—Hot flush—Epirubicin—liver cancer	0.00219	0.00219	CcSEcCtD
Varenicline—Increased appetite—Epirubicin—liver cancer	0.00218	0.00218	CcSEcCtD
Varenicline—Diabetes mellitus—Doxorubicin—liver cancer	0.00218	0.00218	CcSEcCtD
Varenicline—Menopausal symptoms—Epirubicin—liver cancer	0.00217	0.00217	CcSEcCtD
Varenicline—Urticaria—Sorafenib—liver cancer	0.00216	0.00216	CcSEcCtD
Varenicline—Abdominal pain—Sorafenib—liver cancer	0.00215	0.00215	CcSEcCtD
Varenicline—Body temperature increased—Sorafenib—liver cancer	0.00215	0.00215	CcSEcCtD
Varenicline—Eczema—Doxorubicin—liver cancer	0.00211	0.00211	CcSEcCtD
Varenicline—Eye pain—Doxorubicin—liver cancer	0.0021	0.0021	CcSEcCtD
Varenicline—Hypoglycaemia—Epirubicin—liver cancer	0.0021	0.0021	CcSEcCtD
Varenicline—Lethargy—Epirubicin—liver cancer	0.00209	0.00209	CcSEcCtD
Varenicline—Cerebrovascular accident—Epirubicin—liver cancer	0.00209	0.00209	CcSEcCtD
Varenicline—Renal failure acute—Doxorubicin—liver cancer	0.00205	0.00205	CcSEcCtD
Varenicline—Osteoarthritis—Epirubicin—liver cancer	0.00205	0.00205	CcSEcCtD
Varenicline—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00205	0.00205	CcSEcCtD
Varenicline—Hot flush—Doxorubicin—liver cancer	0.00203	0.00203	CcSEcCtD
Varenicline—Increased appetite—Doxorubicin—liver cancer	0.00202	0.00202	CcSEcCtD
Varenicline—Migraine—Epirubicin—liver cancer	0.00202	0.00202	CcSEcCtD
Varenicline—Affect lability—Epirubicin—liver cancer	0.00202	0.00202	CcSEcCtD
Varenicline—Menopausal symptoms—Doxorubicin—liver cancer	0.00201	0.00201	CcSEcCtD
Varenicline—Hypersensitivity—Sorafenib—liver cancer	0.00201	0.00201	CcSEcCtD
Varenicline—Asthenia—Sorafenib—liver cancer	0.00195	0.00195	CcSEcCtD
Varenicline—Hypoglycaemia—Doxorubicin—liver cancer	0.00194	0.00194	CcSEcCtD
Varenicline—Mood swings—Epirubicin—liver cancer	0.00194	0.00194	CcSEcCtD
Varenicline—Cerebrovascular accident—Doxorubicin—liver cancer	0.00193	0.00193	CcSEcCtD
Varenicline—Lethargy—Doxorubicin—liver cancer	0.00193	0.00193	CcSEcCtD
Varenicline—Pruritus—Sorafenib—liver cancer	0.00193	0.00193	CcSEcCtD
Varenicline—Osteoarthritis—Doxorubicin—liver cancer	0.00189	0.00189	CcSEcCtD
Varenicline—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00189	0.00189	CcSEcCtD
Varenicline—Liver function test abnormal—Epirubicin—liver cancer	0.00189	0.00189	CcSEcCtD
Varenicline—Dry skin—Epirubicin—liver cancer	0.00188	0.00188	CcSEcCtD
Varenicline—Abdominal pain upper—Epirubicin—liver cancer	0.00187	0.00187	CcSEcCtD
Varenicline—Migraine—Doxorubicin—liver cancer	0.00186	0.00186	CcSEcCtD
Varenicline—Affect lability—Doxorubicin—liver cancer	0.00186	0.00186	CcSEcCtD
Varenicline—Hypokalaemia—Epirubicin—liver cancer	0.00186	0.00186	CcSEcCtD
Varenicline—Diarrhoea—Sorafenib—liver cancer	0.00186	0.00186	CcSEcCtD
Varenicline—Breast disorder—Epirubicin—liver cancer	0.00185	0.00185	CcSEcCtD
Varenicline—Nasopharyngitis—Epirubicin—liver cancer	0.00183	0.00183	CcSEcCtD
Varenicline—Gastritis—Epirubicin—liver cancer	0.00181	0.00181	CcSEcCtD
Varenicline—Dizziness—Sorafenib—liver cancer	0.0018	0.0018	CcSEcCtD
Varenicline—Mood swings—Doxorubicin—liver cancer	0.00179	0.00179	CcSEcCtD
Varenicline—Abdominal distension—Epirubicin—liver cancer	0.00178	0.00178	CcSEcCtD
Varenicline—Asthma—Epirubicin—liver cancer	0.00177	0.00177	CcSEcCtD
Varenicline—Dysphagia—Epirubicin—liver cancer	0.00177	0.00177	CcSEcCtD
Varenicline—Liver function test abnormal—Doxorubicin—liver cancer	0.00175	0.00175	CcSEcCtD
Varenicline—Dry skin—Doxorubicin—liver cancer	0.00174	0.00174	CcSEcCtD
Varenicline—Vomiting—Sorafenib—liver cancer	0.00173	0.00173	CcSEcCtD
Varenicline—Abdominal pain upper—Doxorubicin—liver cancer	0.00173	0.00173	CcSEcCtD
Varenicline—Hypokalaemia—Doxorubicin—liver cancer	0.00172	0.00172	CcSEcCtD
Varenicline—Angina pectoris—Epirubicin—liver cancer	0.00172	0.00172	CcSEcCtD
Varenicline—Rash—Sorafenib—liver cancer	0.00172	0.00172	CcSEcCtD
Varenicline—Dermatitis—Sorafenib—liver cancer	0.00172	0.00172	CcSEcCtD
Varenicline—Breast disorder—Doxorubicin—liver cancer	0.00171	0.00171	CcSEcCtD
Varenicline—Headache—Sorafenib—liver cancer	0.00171	0.00171	CcSEcCtD
Varenicline—Bronchitis—Epirubicin—liver cancer	0.0017	0.0017	CcSEcCtD
Varenicline—Nasopharyngitis—Doxorubicin—liver cancer	0.00169	0.00169	CcSEcCtD
Varenicline—Gastritis—Doxorubicin—liver cancer	0.00168	0.00168	CcSEcCtD
Varenicline—Abdominal distension—Doxorubicin—liver cancer	0.00165	0.00165	CcSEcCtD
Varenicline—Asthma—Doxorubicin—liver cancer	0.00164	0.00164	CcSEcCtD
Varenicline—Dysphagia—Doxorubicin—liver cancer	0.00164	0.00164	CcSEcCtD
Varenicline—Pollakiuria—Epirubicin—liver cancer	0.00163	0.00163	CcSEcCtD
Varenicline—Nausea—Sorafenib—liver cancer	0.00162	0.00162	CcSEcCtD
Varenicline—Photosensitivity reaction—Epirubicin—liver cancer	0.00162	0.00162	CcSEcCtD
Varenicline—Weight increased—Epirubicin—liver cancer	0.00161	0.00161	CcSEcCtD
Varenicline—Hyperglycaemia—Epirubicin—liver cancer	0.0016	0.0016	CcSEcCtD
Varenicline—Angina pectoris—Doxorubicin—liver cancer	0.0016	0.0016	CcSEcCtD
Varenicline—Infestation—Epirubicin—liver cancer	0.00158	0.00158	CcSEcCtD
Varenicline—Infestation NOS—Epirubicin—liver cancer	0.00158	0.00158	CcSEcCtD
Varenicline—Bronchitis—Doxorubicin—liver cancer	0.00157	0.00157	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00156	0.00156	CcSEcCtD
Varenicline—Stomatitis—Epirubicin—liver cancer	0.00154	0.00154	CcSEcCtD
Varenicline—Conjunctivitis—Epirubicin—liver cancer	0.00153	0.00153	CcSEcCtD
Varenicline—Pollakiuria—Doxorubicin—liver cancer	0.00151	0.00151	CcSEcCtD
Varenicline—Photosensitivity reaction—Doxorubicin—liver cancer	0.00149	0.00149	CcSEcCtD
Varenicline—Hepatobiliary disease—Epirubicin—liver cancer	0.00149	0.00149	CcSEcCtD
Varenicline—Weight increased—Doxorubicin—liver cancer	0.00149	0.00149	CcSEcCtD
Varenicline—Epistaxis—Epirubicin—liver cancer	0.00149	0.00149	CcSEcCtD
Varenicline—Sinusitis—Epirubicin—liver cancer	0.00148	0.00148	CcSEcCtD
Varenicline—Hyperglycaemia—Doxorubicin—liver cancer	0.00148	0.00148	CcSEcCtD
Varenicline—Infestation—Doxorubicin—liver cancer	0.00146	0.00146	CcSEcCtD
Varenicline—Infestation NOS—Doxorubicin—liver cancer	0.00146	0.00146	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00145	0.00145	CcSEcCtD
Varenicline—Bradycardia—Epirubicin—liver cancer	0.00144	0.00144	CcSEcCtD
Varenicline—Stomatitis—Doxorubicin—liver cancer	0.00142	0.00142	CcSEcCtD
Varenicline—Conjunctivitis—Doxorubicin—liver cancer	0.00142	0.00142	CcSEcCtD
Varenicline—Hypoaesthesia—Epirubicin—liver cancer	0.00141	0.00141	CcSEcCtD
Varenicline—Urinary tract disorder—Epirubicin—liver cancer	0.0014	0.0014	CcSEcCtD
Varenicline—Oedema peripheral—Epirubicin—liver cancer	0.0014	0.0014	CcSEcCtD
Varenicline—Connective tissue disorder—Epirubicin—liver cancer	0.00139	0.00139	CcSEcCtD
Varenicline—Urethral disorder—Epirubicin—liver cancer	0.00139	0.00139	CcSEcCtD
Varenicline—Hepatobiliary disease—Doxorubicin—liver cancer	0.00138	0.00138	CcSEcCtD
Varenicline—Epistaxis—Doxorubicin—liver cancer	0.00138	0.00138	CcSEcCtD
Varenicline—Sinusitis—Doxorubicin—liver cancer	0.00137	0.00137	CcSEcCtD
Varenicline—Visual impairment—Epirubicin—liver cancer	0.00137	0.00137	CcSEcCtD
Varenicline—Erythema multiforme—Epirubicin—liver cancer	0.00134	0.00134	CcSEcCtD
Varenicline—Bradycardia—Doxorubicin—liver cancer	0.00133	0.00133	CcSEcCtD
Varenicline—Eye disorder—Epirubicin—liver cancer	0.00132	0.00132	CcSEcCtD
Varenicline—Tinnitus—Epirubicin—liver cancer	0.00132	0.00132	CcSEcCtD
Varenicline—Cardiac disorder—Epirubicin—liver cancer	0.00131	0.00131	CcSEcCtD
Varenicline—Hypoaesthesia—Doxorubicin—liver cancer	0.0013	0.0013	CcSEcCtD
Varenicline—Urinary tract disorder—Doxorubicin—liver cancer	0.00129	0.00129	CcSEcCtD
Varenicline—Oedema peripheral—Doxorubicin—liver cancer	0.00129	0.00129	CcSEcCtD
Varenicline—Connective tissue disorder—Doxorubicin—liver cancer	0.00129	0.00129	CcSEcCtD
Varenicline—Angiopathy—Epirubicin—liver cancer	0.00129	0.00129	CcSEcCtD
Varenicline—Urethral disorder—Doxorubicin—liver cancer	0.00128	0.00128	CcSEcCtD
Varenicline—Immune system disorder—Epirubicin—liver cancer	0.00128	0.00128	CcSEcCtD
Varenicline—Mediastinal disorder—Epirubicin—liver cancer	0.00128	0.00128	CcSEcCtD
Varenicline—Chills—Epirubicin—liver cancer	0.00127	0.00127	CcSEcCtD
Varenicline—Arrhythmia—Epirubicin—liver cancer	0.00127	0.00127	CcSEcCtD
Varenicline—Visual impairment—Doxorubicin—liver cancer	0.00126	0.00126	CcSEcCtD
Varenicline—Mental disorder—Epirubicin—liver cancer	0.00124	0.00124	CcSEcCtD
Varenicline—Erythema multiforme—Doxorubicin—liver cancer	0.00124	0.00124	CcSEcCtD
Varenicline—Erythema—Epirubicin—liver cancer	0.00123	0.00123	CcSEcCtD
Varenicline—Malnutrition—Epirubicin—liver cancer	0.00123	0.00123	CcSEcCtD
Varenicline—Eye disorder—Doxorubicin—liver cancer	0.00122	0.00122	CcSEcCtD
Varenicline—Tinnitus—Doxorubicin—liver cancer	0.00122	0.00122	CcSEcCtD
Varenicline—Cardiac disorder—Doxorubicin—liver cancer	0.00122	0.00122	CcSEcCtD
Varenicline—Flatulence—Epirubicin—liver cancer	0.00122	0.00122	CcSEcCtD
Varenicline—Dysgeusia—Epirubicin—liver cancer	0.00121	0.00121	CcSEcCtD
Varenicline—Back pain—Epirubicin—liver cancer	0.00119	0.00119	CcSEcCtD
Varenicline—Angiopathy—Doxorubicin—liver cancer	0.00119	0.00119	CcSEcCtD
Varenicline—Muscle spasms—Epirubicin—liver cancer	0.00119	0.00119	CcSEcCtD
Varenicline—Immune system disorder—Doxorubicin—liver cancer	0.00118	0.00118	CcSEcCtD
Varenicline—Mediastinal disorder—Doxorubicin—liver cancer	0.00118	0.00118	CcSEcCtD
Varenicline—Chills—Doxorubicin—liver cancer	0.00118	0.00118	CcSEcCtD
Varenicline—Arrhythmia—Doxorubicin—liver cancer	0.00117	0.00117	CcSEcCtD
Varenicline—Vision blurred—Epirubicin—liver cancer	0.00116	0.00116	CcSEcCtD
Varenicline—Mental disorder—Doxorubicin—liver cancer	0.00115	0.00115	CcSEcCtD
Varenicline—Ill-defined disorder—Epirubicin—liver cancer	0.00114	0.00114	CcSEcCtD
Varenicline—Malnutrition—Doxorubicin—liver cancer	0.00114	0.00114	CcSEcCtD
Varenicline—Erythema—Doxorubicin—liver cancer	0.00114	0.00114	CcSEcCtD
Varenicline—Anaemia—Epirubicin—liver cancer	0.00114	0.00114	CcSEcCtD
Varenicline—Agitation—Epirubicin—liver cancer	0.00113	0.00113	CcSEcCtD
Varenicline—Flatulence—Doxorubicin—liver cancer	0.00112	0.00112	CcSEcCtD
Varenicline—Dysgeusia—Doxorubicin—liver cancer	0.00112	0.00112	CcSEcCtD
Varenicline—Malaise—Epirubicin—liver cancer	0.00111	0.00111	CcSEcCtD
Varenicline—Vertigo—Epirubicin—liver cancer	0.00111	0.00111	CcSEcCtD
Varenicline—Syncope—Epirubicin—liver cancer	0.00111	0.00111	CcSEcCtD
Varenicline—Back pain—Doxorubicin—liver cancer	0.0011	0.0011	CcSEcCtD
Varenicline—Muscle spasms—Doxorubicin—liver cancer	0.0011	0.0011	CcSEcCtD
Varenicline—Palpitations—Epirubicin—liver cancer	0.00109	0.00109	CcSEcCtD
Varenicline—Loss of consciousness—Epirubicin—liver cancer	0.00108	0.00108	CcSEcCtD
Varenicline—Cough—Epirubicin—liver cancer	0.00108	0.00108	CcSEcCtD
Varenicline—Vision blurred—Doxorubicin—liver cancer	0.00108	0.00108	CcSEcCtD
Varenicline—Convulsion—Epirubicin—liver cancer	0.00107	0.00107	CcSEcCtD
Varenicline—Hypertension—Epirubicin—liver cancer	0.00106	0.00106	CcSEcCtD
Varenicline—Ill-defined disorder—Doxorubicin—liver cancer	0.00106	0.00106	CcSEcCtD
Varenicline—Anaemia—Doxorubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Varenicline—Arthralgia—Epirubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Varenicline—Chest pain—Epirubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Varenicline—Myalgia—Epirubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Varenicline—Agitation—Doxorubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Varenicline—Anxiety—Epirubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00104	0.00104	CcSEcCtD
Varenicline—Discomfort—Epirubicin—liver cancer	0.00104	0.00104	CcSEcCtD
Varenicline—Malaise—Doxorubicin—liver cancer	0.00103	0.00103	CcSEcCtD
Varenicline—Dry mouth—Epirubicin—liver cancer	0.00103	0.00103	CcSEcCtD
Varenicline—Vertigo—Doxorubicin—liver cancer	0.00103	0.00103	CcSEcCtD
Varenicline—Syncope—Doxorubicin—liver cancer	0.00102	0.00102	CcSEcCtD
Varenicline—Palpitations—Doxorubicin—liver cancer	0.00101	0.00101	CcSEcCtD
Varenicline—Oedema—Epirubicin—liver cancer	0.00101	0.00101	CcSEcCtD
Varenicline—Loss of consciousness—Doxorubicin—liver cancer	0.001	0.001	CcSEcCtD
Varenicline—Infection—Epirubicin—liver cancer	0.001	0.001	CcSEcCtD
Varenicline—Cough—Doxorubicin—liver cancer	0.000996	0.000996	CcSEcCtD
Varenicline—Shock—Epirubicin—liver cancer	0.00099	0.00099	CcSEcCtD
Varenicline—Convulsion—Doxorubicin—liver cancer	0.000989	0.000989	CcSEcCtD
Varenicline—Nervous system disorder—Epirubicin—liver cancer	0.000987	0.000987	CcSEcCtD
Varenicline—Thrombocytopenia—Epirubicin—liver cancer	0.000985	0.000985	CcSEcCtD
Varenicline—Hypertension—Doxorubicin—liver cancer	0.000985	0.000985	CcSEcCtD
Varenicline—Tachycardia—Epirubicin—liver cancer	0.000982	0.000982	CcSEcCtD
Varenicline—Skin disorder—Epirubicin—liver cancer	0.000978	0.000978	CcSEcCtD
Varenicline—Hyperhidrosis—Epirubicin—liver cancer	0.000973	0.000973	CcSEcCtD
Varenicline—Arthralgia—Doxorubicin—liver cancer	0.000971	0.000971	CcSEcCtD
Varenicline—Chest pain—Doxorubicin—liver cancer	0.000971	0.000971	CcSEcCtD
Varenicline—Myalgia—Doxorubicin—liver cancer	0.000971	0.000971	CcSEcCtD
Varenicline—Anxiety—Doxorubicin—liver cancer	0.000968	0.000968	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000965	0.000965	CcSEcCtD
Varenicline—Discomfort—Doxorubicin—liver cancer	0.00096	0.00096	CcSEcCtD
Varenicline—Anorexia—Epirubicin—liver cancer	0.000959	0.000959	CcSEcCtD
Varenicline—Dry mouth—Doxorubicin—liver cancer	0.00095	0.00095	CcSEcCtD
Varenicline—Hypotension—Epirubicin—liver cancer	0.00094	0.00094	CcSEcCtD
Varenicline—Oedema—Doxorubicin—liver cancer	0.000931	0.000931	CcSEcCtD
Varenicline—Infection—Doxorubicin—liver cancer	0.000925	0.000925	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000917	0.000917	CcSEcCtD
Varenicline—Shock—Doxorubicin—liver cancer	0.000916	0.000916	CcSEcCtD
Varenicline—Nervous system disorder—Doxorubicin—liver cancer	0.000913	0.000913	CcSEcCtD
Varenicline—Thrombocytopenia—Doxorubicin—liver cancer	0.000912	0.000912	CcSEcCtD
Varenicline—Insomnia—Epirubicin—liver cancer	0.00091	0.00091	CcSEcCtD
Varenicline—Tachycardia—Doxorubicin—liver cancer	0.000909	0.000909	CcSEcCtD
Varenicline—Skin disorder—Doxorubicin—liver cancer	0.000905	0.000905	CcSEcCtD
Varenicline—Hyperhidrosis—Doxorubicin—liver cancer	0.0009	0.0009	CcSEcCtD
Varenicline—Dyspnoea—Epirubicin—liver cancer	0.000897	0.000897	CcSEcCtD
Varenicline—Somnolence—Epirubicin—liver cancer	0.000895	0.000895	CcSEcCtD
Varenicline—Anorexia—Doxorubicin—liver cancer	0.000888	0.000888	CcSEcCtD
Varenicline—Dyspepsia—Epirubicin—liver cancer	0.000886	0.000886	CcSEcCtD
Varenicline—Decreased appetite—Epirubicin—liver cancer	0.000875	0.000875	CcSEcCtD
Varenicline—Hypotension—Doxorubicin—liver cancer	0.00087	0.00087	CcSEcCtD
Varenicline—Gastrointestinal disorder—Epirubicin—liver cancer	0.000869	0.000869	CcSEcCtD
Varenicline—Fatigue—Epirubicin—liver cancer	0.000868	0.000868	CcSEcCtD
Varenicline—Constipation—Epirubicin—liver cancer	0.000861	0.000861	CcSEcCtD
Varenicline—Pain—Epirubicin—liver cancer	0.000861	0.000861	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000848	0.000848	CcSEcCtD
Varenicline—Insomnia—Doxorubicin—liver cancer	0.000842	0.000842	CcSEcCtD
Varenicline—Dyspnoea—Doxorubicin—liver cancer	0.00083	0.00083	CcSEcCtD
Varenicline—Feeling abnormal—Epirubicin—liver cancer	0.000829	0.000829	CcSEcCtD
Varenicline—Somnolence—Doxorubicin—liver cancer	0.000828	0.000828	CcSEcCtD
Varenicline—Gastrointestinal pain—Epirubicin—liver cancer	0.000823	0.000823	CcSEcCtD
Varenicline—Dyspepsia—Doxorubicin—liver cancer	0.00082	0.00082	CcSEcCtD
Varenicline—Decreased appetite—Doxorubicin—liver cancer	0.00081	0.00081	CcSEcCtD
Varenicline—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000804	0.000804	CcSEcCtD
Varenicline—Fatigue—Doxorubicin—liver cancer	0.000803	0.000803	CcSEcCtD
Varenicline—Urticaria—Epirubicin—liver cancer	0.0008	0.0008	CcSEcCtD
Varenicline—Pain—Doxorubicin—liver cancer	0.000796	0.000796	CcSEcCtD
Varenicline—Constipation—Doxorubicin—liver cancer	0.000796	0.000796	CcSEcCtD
Varenicline—Abdominal pain—Epirubicin—liver cancer	0.000796	0.000796	CcSEcCtD
Varenicline—Body temperature increased—Epirubicin—liver cancer	0.000796	0.000796	CcSEcCtD
Varenicline—Feeling abnormal—Doxorubicin—liver cancer	0.000767	0.000767	CcSEcCtD
Varenicline—Gastrointestinal pain—Doxorubicin—liver cancer	0.000761	0.000761	CcSEcCtD
Varenicline—Hypersensitivity—Epirubicin—liver cancer	0.000742	0.000742	CcSEcCtD
Varenicline—Urticaria—Doxorubicin—liver cancer	0.00074	0.00074	CcSEcCtD
Varenicline—Body temperature increased—Doxorubicin—liver cancer	0.000736	0.000736	CcSEcCtD
Varenicline—Abdominal pain—Doxorubicin—liver cancer	0.000736	0.000736	CcSEcCtD
Varenicline—Asthenia—Epirubicin—liver cancer	0.000722	0.000722	CcSEcCtD
Varenicline—Pruritus—Epirubicin—liver cancer	0.000712	0.000712	CcSEcCtD
Varenicline—Diarrhoea—Epirubicin—liver cancer	0.000689	0.000689	CcSEcCtD
Varenicline—Hypersensitivity—Doxorubicin—liver cancer	0.000686	0.000686	CcSEcCtD
Varenicline—Asthenia—Doxorubicin—liver cancer	0.000668	0.000668	CcSEcCtD
Varenicline—Dizziness—Epirubicin—liver cancer	0.000666	0.000666	CcSEcCtD
Varenicline—Pruritus—Doxorubicin—liver cancer	0.000659	0.000659	CcSEcCtD
Varenicline—Vomiting—Epirubicin—liver cancer	0.00064	0.00064	CcSEcCtD
Varenicline—Diarrhoea—Doxorubicin—liver cancer	0.000637	0.000637	CcSEcCtD
Varenicline—Rash—Epirubicin—liver cancer	0.000635	0.000635	CcSEcCtD
Varenicline—Dermatitis—Epirubicin—liver cancer	0.000634	0.000634	CcSEcCtD
Varenicline—Headache—Epirubicin—liver cancer	0.00063	0.00063	CcSEcCtD
Varenicline—Dizziness—Doxorubicin—liver cancer	0.000616	0.000616	CcSEcCtD
Varenicline—Nausea—Epirubicin—liver cancer	0.000598	0.000598	CcSEcCtD
Varenicline—Vomiting—Doxorubicin—liver cancer	0.000592	0.000592	CcSEcCtD
Varenicline—Rash—Doxorubicin—liver cancer	0.000587	0.000587	CcSEcCtD
Varenicline—Dermatitis—Doxorubicin—liver cancer	0.000587	0.000587	CcSEcCtD
Varenicline—Headache—Doxorubicin—liver cancer	0.000583	0.000583	CcSEcCtD
Varenicline—Nausea—Doxorubicin—liver cancer	0.000553	0.000553	CcSEcCtD
